Adelaide, Australia – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced it will showcase its world-class immunoassay and immunobiology services for regulated bioanalysis at Bio-Europe 2021.
Dr Kurt J. Sales Agilex Biolabs’ Director Immunoassay said:
“Our experienced team can develop or transfer a method for any biologic to support pre-clinical GLP or clinical studies.
Our world-class laboratories feature state-of-the-art equipment including Gyrolab Xplore, MSD Quickplex 120, Luminex Magpix, BD FACSymphony A3 flow cytometer and soon to be released, digital droplet quantitative real-time RT-PCR.
Our scientists have expertise and experience to solve the most complex immunogenicity and drug tolerance issues, often encountered in immuno-oncology studies in both an early phase and later phase setting.”
Agilex Biolabs also features a rebate of up to 43.5% on clinical trial bioanalytical services spend as part of the Australian Government clinical trial attraction program.
Learn more: Take a briefing with our Scientists at Bio-Europe via PartneringOne Login Here
Or Book a Briefing with us before you start your next clinical trial.
또한 애자일렉스 바이오랩스는 NATA(호주 정부 OECD GLP 준수 모니터링 기관)의 OECD GLP 인증과 ISO 17025 인증 등 주요 인증을 획득하여 세계적으로 인정받고 있습니다.
호주의 임상시험은 계속 진행 중이며, 애질렉스 바이오랩은 고객이 연구의 연속성을 보장받을 수 있도록 지정된 필수 서비스입니다.
호주는 소규모 집단 감염에 신속하게 대응하여 전 세계에서 코로나19 확진자 수를 거의 0명으로 낮추는 데 앞장서고 있습니다.
The company has recently expanded its labs by more than 30% to accommodate biotech demand from APAC, EU and the USA. Watch the New Labs Walkthrough Video Here https://www.agilexbiolabs.com/new-labs-video
Agilex Biolabs has more than 100 staff which includes 75 dedicated laboratory staff.
애자일렉스 바이오랩스 소개 https://www.agilexbiolabs.com/
Agilex Biolabs, Australia’s leading bioanalytical laboratory, has more than 24 years’ experience in performing regulated bioanalysis, including quality method development, method validation and sample analysis services. We have successfully supported hundreds of preclinical and clinical trials around the world where customers choose Australia for the streamlined regulatory process and access to the world’s most attractive R&D rebate of more than 40% on clinical trial work conducted in Australia.
We offer services for both small molecules and biologics for PK, immunogenicity (PD) and biomarker bioanalysis utilising the two platforms of LC-MS/MS and Immunoassay.
